COVID-19

This page is dedicated to providing updates and resources for the sickle cell community amid the current COVID-19 public health situation. Please continue to check back for more updates and information.   

May 12, 2020

Correspondence

Africa faces difficult choices in responding to COVID-19

May 6, 2020

Correspondence

COVID-19 on the African continent

April 3, 2020

Journal Article 

COVID‐19 Pneumonia as a Cause of Acute Chest Syndrome in an Adult Sickle Cell Patient

The Medical and Research Advisory Committee (MARAC) at SCDAA is providing suggested guidelines for the acute and chronic disease management of patients with SCD living in Sub-Saharan Africa. 

Sickle Cell Disease and COVID-19: An Outline to Decrease Burden and Minimize Morbidity- Adapted for Sub-Saharan Africa

Input from Drs. Arun Shet, Ken Ataga, Ted Wun, Matthew Hseih, Allison King, Rakhi Naik, Alexis Thompson, Michael DeBaun

COVID-19 and Sickle Cell Disease: Frequently Asked Questions

May 7, 2020

Report

Responding to COVID-19 in Africa: Using Data to Find a Balance

April 23, 2020

Comment

Mitigating the effect of the COVID-19 pandemic on sickle cell disease services in African countries

This registry is designed to capture pediatric and adult COVID-19 cases that are occurring across the world in patients living with sickle cell disease. The goal of the registry is to report on outcomes of cases of COVID-19 in this population of patients. We are asking providers caring for these patients to report all of their cases of COVID-19 to this registry.

SECURE-SCD Registry

The Medical and Research Advisory Committee (MARAC) at SCDAA is providing suggested recommendations for COVID-19 preparedness for people living with sickle cell disease and their caregivers.

Recommendations for Coronavirus (COVID-19) Preparedness

May 7, 2020

Viewpoint

Access to lifesaving medical resources for African countries: COVID-19 testing and response, ethics, and politics

April 3, 2020

Journal Article 

Vaso-Occlusive Crisis and Acute Chest Syndrome in Sickle Cell Disease due to 2019 Novel Coronavirus Disease (COVID19)

The Medical and Research Advisory Committee (MARAC) at SCDAA is providing suggested guidelines for the acute and chronic disease management of patients with SCD given the multidimensional and evolving changes and challenges in the healthcare operational landscape.

Sickle Cell Disease and COVID-19: An Outline to Decrease Burden and Minimize Morbidity

The Medical and Research Advisory Committee (MARAC) at SCDAA is providing suggested recommendations for COVID-19 preparedness for people living with sickle cell disease and their caregivers living in Sub-Saharan Africa.

Recommendations for Coronavirus (COVID-19) Preparedness- Adapted for Sub-Saharan Africa

  • Twitter - White Circle

Copyright © 2020 The Global Sickle Cell Disease Network